| Univariable analysis | Multivariable analysisa | ||
---|---|---|---|---|
HR (95% CI) | P | AHR (95% CI) | P | |
Age, per 10-year increase | 2.00 (1.71–2.32) | < 0.001 | 1.47 (1.21–1.77) | < 0.001 |
Male sex | 1.09 (0.15–7.86) | 0.93 | 3.67 (0.48–28.34) | 0.21 |
HIV transmission route | ||||
 Homosexual | 1.00 (Reference) |  | 1.00 (Reference) |  |
 Heterosexual | 5.38 (3.03–9.55) | < 0.001 | 2.61 (1.32–5.16) | 0.006 |
 Bisexual | 2.67 (1.03–6.90) | 0.043 | 1.86 (0.71–4.88) | 0.21 |
 IDU | 2.64 (0.36–19.38) | 0.34 | 1.98 (0.26–14.98) | 0.51 |
 Unknown | 11.14 (2.65–46.78) | 0.001 | 5.87 (1.27–27.08) | 0.011 |
Period | ||||
 Period 1 | 1.00 (Reference) |  |  |  |
 Period 2 | 1.32 (0.72–2.43) | 0.37 | 1.48 (0.80–2.76) | 0.21 |
 Period 3 | 0.71 (0.34–1.48) | 0.35 | 0.92 (0.43–1.95) | 0.82 |
Subgroup of CD4 cell count at presentation | 17.59 (7.02–44.07) | < 0.001 |  |  |
 CD4 count ≥500 cells/μL | 1.00 (Reference) |  | 1.00 (Reference) |  |
 CD4 count 200–499 cells/μL | 1.29 (0.15–11.03) | 0.82 | 1.21 (0.14–10.42) | 0.86 |
 CD4 count < 200 cells/μL | 16.86 (2.33–122.04) | 0.005 | 11.03 (1.51–80.64) | 0.018 |
HBsAg seropositivity | 3.30 (1.80–6.05) | < 0.001 | 2.65 (1.42–4.94) | 0.002 |